Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir




Nieminen TH, Hagelberg NM, Saari TI, Neuvonen M, Neuvonen PJ, Laine K, Olkkola KT

PublisherSPRINGER HEIDELBERG

2010

European Journal of Clinical Pharmacology

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

EUR J CLIN PHARMACOL

10

66

10

977

985

9

0031-6970

DOIhttps://doi.org/10.1007/s00228-010-0879-1



Ritonavir and lopinavir/ritonavir greatly increase the plasma concentrations of oral oxycodone in healthy volunteers and enhance its effect. When oxycodone is used clinically in patients during ritonavir and lopinavir/ritonavir treatment, reductions in oxycodone dose may be needed to avoid opioid-related adverse effects.



Last updated on 2024-26-11 at 20:08